4Chakrabarti S,Raha K, Bhunia CL,et al. The usefulness of prostate specific antigen density as a screening method for prostatic carcinoma[J]. J Indian Med Assoc, 2001 ; 99 (11): 627-628.
5Hofer C,Sauerstein P,Wolter C,et al. Value of free prostate specific antigen (Hybritech Tandem-R) in symptomatic patients consulting the urologist [J].Urol Int,2000; 64(1): 18-23.
6Gaspar MJ,Arribas I, Hontoria JM,et al. Usefulness of the percentage of free prostatic specific antigen in the differential diagnosis between benign prostatic hyperplasia and prostate cancer [J]. Med Clin (Barc), 2000;115 (9): 332-336.
4Jung K,Elgeti U,Lein M,et al.Ratio of free or complexed prostate-specific antigen (PSA) to total PSA:which ratio improves differentiation between benign prostatic hyperplasia and prostate cancer?[J].Clin Chem,2000,46 (1):55-62.
6Demura T, Shinohara N, Tanaka M, et al. The proportion of free - total prostate specific antigen: a method of detecting prostate carcinoma. Cancer, 1996,77 ( 6 ) : 1137-1143.
8Tombal B, Querton M, Nayer P, et al. Free / total PSA ratio does not improve prediction of pathologic stage and biochemical recurrence after radical p mstatectomy. Urology, 2009,59:256- 260.
9Y. Furuya,K. Akakura,H. Ito.Value of free-to-total prostate-specific antigen ratio for detection and staging of prostate cancer[J]. International Journal of Clinical Oncology . 2000 (1)
10Minardi D,Galosi AB,Recchioni A,et al.Diagnostic accu-racy of percent free prostate-specific antigen in pathologyand its usefulness in monitoning prostatic cancer patients. Urologia Internationalis . 2001
